GlaxoSmithKline Prize [SEP] conferred by
GlaxoSmithKline Prize
The GlaxoSmithKline Prize and Lecture is awarded by the Royal Society of London "for original contributions to medical and veterinary sciences published within ten years from the date of the award". Sponsored by GlaxoSmithKline, the medal is awarded with a gift of £2500. The medal was first awarded in 1980 to César Milstein "in recognition of his pioneering the production of monoclonal antibodies from hybrid cell lines and initiating their application worldwide in many fields of biology and medicine", and has since been awarded 13 times.
decrease the binding affinity between pyrimethamine and dihydrofolate reductase via loss of hydrogen bonds and steric interactions.
History.
Nobel Prize-winning American scientist Gertrude Elion developed the drug at Burroughs-Wellcome (now part of GlaxoSmithKline) to combat malaria. Pyrimethamine has been available since 1953. In 2010, GlaxoSmithKline sold the marketing rights for Daraprim to CorePharma. Impax Laboratories sought to buy CorePharma in 2014, and completed the acquisition, including Daraprim, in March 2015. In August 2015, the rights were bought by Turing Pharmaceuticals.